Vitalhub (VHI) Competitors

C$6.95
+0.32 (+4.83%)
(As of 11:03 AM ET)

VHI vs. KSI, DR, FRX, OGI, QIPT, HTL, CPH, CRDL, MDNA, and ACB

Should you be buying Vitalhub stock or one of its competitors? The main competitors of Vitalhub include kneat.com (KSI), Medical Facilities (DR), Fennec Pharmaceuticals (FRX), Organigram (OGI), Quipt Home Medical (QIPT), Hamilton Thorne (HTL), Cipher Pharmaceuticals (CPH), Cardiol Therapeutics (CRDL), Medicenna Therapeutics (MDNA), and Aurora Cannabis (ACB). These companies are all part of the "medical" sector.

Vitalhub vs.

kneat.com (TSE:KSI) and Vitalhub (TSE:VHI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

Vitalhub has a net margin of 8.66% compared to Vitalhub's net margin of -41.26%. kneat.com's return on equity of 5.78% beat Vitalhub's return on equity.

Company Net Margins Return on Equity Return on Assets
kneat.com-41.26% -69.31% -14.72%
Vitalhub 8.66%5.78%3.81%

Vitalhub received 5 more outperform votes than kneat.com when rated by MarketBeat users. However, 100.00% of users gave kneat.com an outperform vote while only 66.67% of users gave Vitalhub an outperform vote.

CompanyUnderperformOutperform
kneat.comOutperform Votes
1
100.00%
Underperform Votes
No Votes
VitalhubOutperform Votes
6
66.67%
Underperform Votes
3
33.33%

kneat.com has a beta of 1.01, suggesting that its share price is 1% more volatile than the S&P 500. Comparatively, Vitalhub has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500.

11.1% of kneat.com shares are owned by institutional investors. Comparatively, 16.9% of Vitalhub shares are owned by institutional investors. 24.7% of kneat.com shares are owned by company insiders. Comparatively, 18.4% of Vitalhub shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Vitalhub has a consensus price target of C$7.25, suggesting a potential upside of 4.32%. Given kneat.com's higher probable upside, analysts plainly believe Vitalhub is more favorable than kneat.com.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
kneat.com
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Vitalhub
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Vitalhub has higher revenue and earnings than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
kneat.comC$34.22M10.22-C$14.12M-C$0.18-23.00
VitalhubC$52.51M6.71C$4.55MC$0.1069.50

In the previous week, kneat.com had 1 more articles in the media than Vitalhub. MarketBeat recorded 8 mentions for kneat.com and 7 mentions for Vitalhub. Vitalhub's average media sentiment score of 0.45 beat kneat.com's score of -0.33 indicating that kneat.com is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
kneat.com
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Vitalhub
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Vitalhub beats kneat.com on 12 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VHI vs. The Competition

MetricVitalhubHealth Information Services IndustryMedical SectorTSE Exchange
Market CapC$352.30MC$228.62MC$5.07BC$5.12B
Dividend YieldN/A6.26%36.92%5.48%
P/E Ratio69.50631.46127.9824.50
Price / Sales6.71579.292,316.951,574.90
Price / CashN/A38.9335.5676.27
Price / Book3.725.005.503.53
Net IncomeC$4.55M-C$5.20MC$104.35MC$286.62M
7 Day Performance5.78%0.22%0.99%0.57%
1 Month Performance15.83%-1.00%2.43%2.11%
1 Year Performance154.58%-10.19%5.85%22.45%

Vitalhub Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KSI
kneat.com
0 of 5 stars
C$4.14
-2.1%
N/A+58.0%C$349.66MC$34.22M-23.00293Analyst Revision
DR
Medical Facilities
0.4401 of 5 stars
C$11.80
+0.9%
C$12.00
+1.7%
+36.7%C$291.70MC$445.58M11.801,833Analyst Revision
FRX
Fennec Pharmaceuticals
0 of 5 stars
C$10.02
-27.0%
N/A-0.3%C$271.54MC$21.25M-12.2229News Coverage
Gap Down
High Trading Volume
OGI
Organigram
2.1144 of 5 stars
C$2.48
-1.2%
C$3.85
+55.2%
+306.6%C$255.44MC$149.21M-0.99984News Coverage
Gap Down
QIPT
Quipt Home Medical
0 of 5 stars
C$5.50
-0.4%
C$11.74
+113.5%
N/AC$234.14MC$235.72M-45.83N/ANews Coverage
HTL
Hamilton Thorne
0 of 5 stars
C$1.40
+2.9%
N/AN/AC$213.86MC$67.23M-140.00N/AAnalyst Revision
CPH
Cipher Pharmaceuticals
0.3733 of 5 stars
C$8.69
-1.5%
C$8.75
+0.7%
+148.3%C$209.52MC$21.16M7.905Analyst Downgrade
News Coverage
CRDL
Cardiol Therapeutics
0 of 5 stars
C$2.95
-2.0%
N/A+293.3%C$201.40MN/A-6.70N/AUpcoming Earnings
News Coverage
MDNA
Medicenna Therapeutics
0 of 5 stars
C$2.56
+4.1%
N/A+172.3%C$191.44MN/A-11.1316
ACB
Aurora Cannabis
0.0333 of 5 stars
C$9.56
+5.1%
C$2.26
-76.3%
+1,174.7%C$521.40MC$275.88M-0.121,130Gap Up

Related Companies and Tools

This page (TSE:VHI) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners